Výsledky vyhledávání - "Joseph Muscato"

An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphoma

Autor: Lina Asmar, Kristi A. Boehm, Craig W. Reynolds, Nicholas J. Di Bella, David C. Faragher, Joseph Muscato

Publikováno v: Cancer. 103:978-984

BACKGROUND In a previous study, the authors demonstrated that the combination of pentostatin (P) and rituximab (R) was well tolerated and was active in patients with low-grade non-Hodgkin lymphoma (NHL). In the current study, mitoxantrone (M) was add

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8889777f9e5a72e7c98cebb0a9750aca
https://doi.org/10.1002/cncr.20820

Zobrazit plný text záznamu

A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy

Autor: Julie R. Gralow, Joseph Muscato, Joyce O'Shaughnessy, Marcus A. Neubauer, LaTrice G. Vaughn, Mauro Orlando, Oluwatoyin O. Shonukan, John Pippen, Anthony D. Elias, Yanping Wang, Christopher Stokoe

Publikováno v: Clinical breast cancer. 10(2)

Purpose This phase II trial assessed efficacy and safety of pemetrexed plus gemcitabine to treat metastatic or locally advanced breast cancer in patients previously treated with taxanes. Patients and Methods Eligible women with advanced breast cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b45a546edec6569fa3fa8daa90fbba76
https://pubmed.ncbi.nlm.nih.gov/20299319

Zobrazit plný text záznamu

Peripheral Blood Stem Cell Mobilization by Chemotherapy With and Without Recombinant Human Granulocyte Colony-Stimulating Factor

Autor: Robert Birch, Christopher George, Lee S. Schwartzberg, Joseph Muscato, Kurt W. Tauer, Ralph Blanco, Paul Lee, William H. West, Fred Wittlin, Rand Altemose, Bonni Hazelton, James Cohen

Publikováno v: Journal of Hematotherapy. 1:317-327

Chemotherapy can serve as a stimulus for mobilizing hematopoietic progenitor cells to the peripheral blood for harvest via leukapheresis. Mobilized peripheral blood stem cells (PBSC) support rapid hematologic reconstitution after bone marrow aplasia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b49b7f2ca1fde21ab68788c56f4eb04
https://doi.org/10.1089/scd.1.1992.1.317

Zobrazit plný text záznamu

Akademický článek

An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphomaThe following medical oncologists from USON network institutions participated in the current study: Elsayed Aly (Indianapolis, IN); Robert Anderson (Waco, TX); Maury B. Berger (Ocala, FL); William R. Berry (Cary, NC); Rudolf H. Good (Sherman, TX); William J. Hyman (Tyler, TX); Lowell F. Inhorn (Roanoke, VA); Paul R. Kuefler (Flagstaff, AZ); Robert McCreary (Clearwater, FL); Anton Melnyk, Jr. (Abilene, TX); Mark C. Myron (Overland Park, KS); Christina W. Prillaman (Williamsburg, VA); Robert Quackenbush (Spokane, WA); Gerald Robbins (Hudson, FL); Michael Roberts (Scottsdale, AZ); Virgil L. Rose, Jr. (Raleigh, NC); Gerald L. Schertz (Roanoke, VA); Ralph Weinstein (Portland, OR); Gary B. Weiss (Webster, TX); and Nini Wu (Albany, NY).

Autor: Nicholas Di Bella, Craig Reynolds, David Faragher, Joseph Muscato, Kristi A. Boehm, Lina Asmar

Publikováno v: Cancer (0008543X); Feb2005, Vol. 103 Issue 5, p978-984, 7p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání